mequitazine has been researched along with Hypersensitivity in 10 studies
mequitazine: RN given refers to parent cpd without isomeric designation; structure
Hypersensitivity: Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Seldom, ENT allergy may be or become life-threatening." | 1.34 | [Allergies in ENT]. ( De Rotalier, P; Fall, D; Faye, M; Sissokho, B, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Rotalier, P | 1 |
| Faye, M | 1 |
| Sissokho, B | 1 |
| Fall, D | 1 |
| Il'ina, NI | 1 |
| Latysheva, TV | 1 |
| Varfolomeeva, MI | 1 |
| Fonlupt, P | 1 |
| Dubois, M | 1 |
| Gallet, H | 1 |
| Biot, N | 1 |
| Pacheco, H | 1 |
| Yakuo, I | 1 |
| Ishii, K | 1 |
| Seto, Y | 1 |
| Imano, K | 1 |
| Takeyama, K | 1 |
| Nakamura, H | 1 |
| Karasawa, T | 1 |
| Blamoutier, J | 1 |
| Tasaka, K | 1 |
| Akagi, M | 1 |
| Mio, M | 1 |
| Izushi, K | 1 |
| Aoki, I | 1 |
| Kosturkov, G | 1 |
| Mileva, Zh | 1 |
| Racheva, R | 1 |
| Boĭkikeva, M | 1 |
| Mustakov, B | 1 |
| Lantin, JP | 1 |
| Pécoud, A | 2 |
| Brandon, ML | 1 |
1 trial available for mequitazine and Hypersensitivity
| Article | Year |
|---|---|
Comparative trial of two antihistamines, mequitazine and brompheniramine.
Topics: Brompheniramine; Clinical Trials as Topic; Double-Blind Method; Female; Histamine H1 Antagonists; Hu | 1978 |
9 other studies available for mequitazine and Hypersensitivity
| Article | Year |
|---|---|
[Allergies in ENT].
Topics: Adrenal Cortex Hormones; Adult; Anaphylaxis; Angioedema; Anti-Allergic Agents; Anti-Asthmatic Agents | 2007 |
[Experience in clinical use of primalan (mequitazine) in allergology].
Topics: Adolescent; Adult; Aged; Child; Female; Histamine H1 Antagonists; Humans; Hypersensitivity; Male; Mi | 2003 |
[Changes in leukocyte phospholipid-N-methyltransferase activity after chronic treatment of allergic patients with mequitazine].
Topics: Humans; Hypersensitivity; Leukocytes; Methyltransferases; Phenothiazines; Phosphatidyl-N-Methylethan | 1983 |
[Pharmacological study of ebastine, a novel histamine H1-receptor antagonist].
Topics: Administration, Oral; Animals; Butyrophenones; Disease Models, Animal; Dose-Response Relationship, D | 1994 |
Anti-platelet activating factor, anti-leukotriene D4 and some other antiallergic activities of mequitazine.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Calcium; Cyclic AMP; Guinea Pigs; Hemolysis; Histamine | 1990 |
[The first impressions of the therapeutic effect of mequitazine (Primalan) in allergic patients].
Topics: Adolescent; Adult; Child; Child, Preschool; Dermatitis, Atopic; Drug Evaluation; Female; Histamine H | 1990 |
[Optimal use of antihistaminics].
Topics: Astemizole; Asthma; Benzhydryl Compounds; Benzimidazoles; Female; Histamine H1 Antagonists; Humans; | 1989 |
Newer non-sedating antihistamines. Will they replace older agents?
Topics: Astemizole; Benzhydryl Compounds; Benzimidazoles; Histamine H1 Antagonists; Humans; Hypersensitivity | 1985 |
[A new generation of H1-receptor antagonist antihistaminics].
Topics: Astemizole; Benzhydryl Compounds; Benzimidazoles; Histamine H1 Antagonists; Hypersensitivity; Phenot | 1986 |